Advances made in healthcare in recent years are extraordinary. 

Today we have effective treatment options for conditions that in living memory would have cut lives cruelly short. This is because of a painstaking process of tracking patterns of disease and experimenting with new treatments.

The NHS can find it difficult to protect clinicians’ time for this sort of meaningful research, which makes such a difference to the length and quality of the lives of people with serious heart and lung conditions. The urgent need to help today’s patients can too easily distract from the important work that helps us do more tomorrow. This is why we are launching our Early Careers Fund.

What is the Early Careers Fund?

The Early Careers Fund will allow clinicians to ringfence time for research, meaning that hospitals don’t have to make the choice between clinical care and research.

The hospitals will also benefit from new ideas and better treatment options without having to reduce time available for diagnosis, treatment and support.

What will we fund?

At Royal Brompton and Harefield Hospitals Charity, we believe the biggest difference we can make is in the early years of a healthcare career, where the right sort of support can catalyse a lifetime of work as a clinician-researcher. Our Early Careers Fund will provide funding for:

  • two newly promoted consultants to ringfence 50% of their time for research over four years
  • annual fellowship awards open to a wide range of healthcare professions, including nurses, midwives, psychologists, allied healthcare professionals and others, to explore their ideas and find new insights into the care for people with heart and lung conditions
  • annual awards designed to encourage the integration of research into the day-to-day working of a clinical team.

Secure the future of care

Can you help secure the future of care for heart and lung patients? Donate to the Early Careers Fund and you will be supporting pioneering research at the hospitals. This vital work will ensure that we can continue to make extraordinary advances in healthcare.